Mortality is associated with COPD exacerbation and a key goal of management of stable COPD is prevention of an AECOPD
The office is so beautiful
It is estimated that more than 16.5 million people in Brazil live with diabetes
It claimed 'GLP-1s for diabetes could be sold at a profit for just US $0.89 per month, compared to the price of $95 per month charged in Brazil, $115 per month charged in South Africa, $230 charged in Latvia and $353 charged in the US, which is a 39,562% markup over what the estimated generic price could be.' Christa Cepuch, Pharmacist Coordinator at MSF's Access Campaign, argues 'These new drugs are an absolute game changer for people living with diabetes, but are being kept out of the hands of hundreds of millions of people in low- and middle-income countries who need them' (Barber, Gotham, Bygrave
She encourages practitioners to frame GLP-1 therapies as tools to jumpstart change, not as long-term solutions